Product information

From Health Canada

New search

Current status:

Marketed

Current status date:

2012-10-01

Original market date: See footnote 1

2012-10-01

Product name:

ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USP

Description:

FOR USE WITH APHERESIS DEVICES ONLY. NOT FOR DIRECT I.V. INFUSION.

DIN:

02377411 Electronic product monograph is not available

Company: 

HAEMONETICS CORPORATION
125 Summer St
Boston
Massachusetts
United States  02110

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

0-Unassigned

Number of active ingredient(s):

1

Schedule(s):

Ethical  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

20:12.04.92   MISCELLANEOUS ANTICOAGULANTS

Anatomical Therapeutic Chemical (ATC): See footnote 4

V07AC  BLOOD TRANSFUSION, AUXILIARY PRODUCTS

Active ingredient group (AIG) number:See footnote 5

0153063001

List of active ingredient(s)
Active ingredient(s) Strength
SODIUM CITRATE DIHYDRATE 4 G / 100 ML

Application information

Related information

Contact us

Version 3.8.0
Date modified: